Pepeliaev Group advises that, on 3 July, the Russian President signed Federal Law No. 358-FZ “On amending certain items of the legislation of the Russian Federation to enhance the state regulation of genetic engineering”.
Pepeliaev Group reports that the Russian Supreme Court has eliminated a contradiction in the case law, confirming that local tax authorities are restricted in controlling the prices of transactions.
Pepeliaev Group advises that 19 April 2016 will see the adoption, under the auspices of the Association of European Business's Healthcare and Pharmaceuticals Committee, of a Code for Good-faith Practices in the Pharmaceutical Sector.
